Bausch Health Companies | VRX - Umsatzkosten

Aktienkurs
6.81
Täglich Wechseln
-0.21 -2.99%
Monatlich
-18.64%
Jährlich
-31.90%
Q1 Prognose
6.73




Umsatzkosten Veränderung Datum
Amgen USD 1.79B 128M 2025-12
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Bausch Health Companies USD 1.03B 284M 2025-12
Biogen USD 810.1M 205.1M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Danaher USD 2.87B 342M 2025-12
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novo Nordisk DKK 15.15B 2.3B 2025-12
Pacira USD 54.62M 6.02M 2025-12
Perrigo USD 747.4M 81.2M 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12
Zoetis USD 743M 60M 2025-12